Related Experiment Videos
Regulation of mast cell activation by complement-derived peptides
Anna Erdei1, Márton Andrásfalvy, Hajna Péterfy
1Department of Immunology, Research Group of the Hungarian Academy of Sciences, Eötvös Loránd University, Pázmány Péter s. 1/C, H-1117 Budapest, Hungary. anna.erdei@freemail.hu
Immunology Letters
|April 15, 2004
Summary
Complement peptides C3a and C5a activate some immune cells but not mucosal mast cells. However, C3a can inhibit these mast cells, suggesting dual roles in immune regulation.
Area of Science:
- Immunology
- Complement System Biology
- Cellular Signaling
Background:
- Complement-derived anaphylatoxic peptides, including C3a, C4a, and C5a, are known potent activators of basophils and certain mast cells.
- Receptors for C3a and C5a are widely distributed beyond myeloid cells, but notably absent on mucosal-type mast cells, rendering them unresponsive to these peptides.
Purpose of the Study:
- To investigate the specific effects of C3a and related peptides on mucosal-type mast cells.
- To explore the potential inhibitory roles of C3a on mast cell activation pathways.
Main Methods:
- Utilized RBL-2H3 cells and bone-marrow derived mast cells as models for mucosal-type mast cells.
- Assessed the impact of C3a and related peptides on FcεRI-clustering induced mast cell activation.
Main Results:
- Demonstrated that C3a and related peptides inhibit FcεRI-clustering induced activation of mucosal-type mast cells.
- Observed no activation of these mast cells by C3a and C5a, consistent with the lack of specific receptors.
Conclusions:
- Proposed the existence of distinct 'activator' and 'inhibitor' sequence motifs within the C3a peptide.
- Hypothesized that these motifs are in a functional balance under physiological conditions, modulating mast cell responses.